Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients

Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients

Aim. To evaluate the real-world clinical practice implementation of modern international and national recommendations on primary and secondary prevention and pharmacotherapy of cardiovascular disease (CVD) among patients with Type 2 diabetes mellitus (DM-2) in one administrative area of Moscow City...

Full description

Bibliographic Details
Main Authors:	R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, Yu. Yu. Tsiruleva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	сердечно-сосудистые заболевания сахарный диабет профилактика лечение
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1645

Similar Items

PREVENTIONAL SCREENING: ALL PROS AND CONTRAS
by: N. V. Pogosova, et al.
Published: (2016-06-01)

Kardiovaskulyarnye narusheniya u detey pri sakharnom diabete
by: O A Dianov, et al.
Published: (2005-12-01)

КЛИНИЧЕСКИЕ И ПРОГНОСТИЧЕСКИЕ АСПЕКТЫ МИКРОАЛЬБУМИНУРИИ У ЖИТЕЛЕЙ ГОРОДА ТВЕРИ
by: О. Б. Поселюгина
Published: (2014-12-01)

FOLLOWING THE PROBLEM OF PROGNOSIS AND COURSE OF CARDIOVASCULAR DISEASES AND DIABETES
by: B. U. Mardanov, et al.
Published: (2015-02-01)

Pharmacoeconomical aspects of the treatment of arterial hypertension in patients with type II diabetes mellitus in outpatient department
by: J Sh Gushina, et al.
Published: (2009-03-01)

Guidelines on diabetes, pre-diabetes and cardiovascular diseases. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), 2007
by: Editorial team Diabetes Mellitus
Published: (2008-03-01)

Associations of cardiovascular diseases and type 2 diabetes with ophthalmic diseases in a population sample over 55 years old
by: A. O. Direev, et al.
Published: (2021-11-01)

PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE
by: M. N. Mamedov, et al.
Published: (2015-12-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
by: I. E. Chazova, et al.
Published: (2021-05-01)

Statins and diabetes mellitus: risks and benefits
by: O. M. Drapkina, et al.
Published: (2012-12-01)

EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS
by: E. V. Akhmedova, et al.
Published: (2015-09-01)

Coffee and cardiovascular risk: what is new?
by: G. Ya. Maslennikova, et al.
Published: (2009-08-01)

Evidence-based principles of early diagnostics of carbohydrate metabolism disturbances in the internal disease practice
by: E. A. Poddubskaya, et al.
Published: (2012-10-01)

EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION
by: M. N. Kovrigina, et al.
Published: (2013-04-01)

THE INFLUENCE OF SUBCLINICAL NEPHROPATHY ON THE SUBJECTIVE HEALTH’S EVALUATION OF PATIENTS WITH MELLITUS DIABETES
by: Maria Gennad’evna Evsina, et al.
Published: (2018-03-01)

Long-term effectiveness of secondary prevention in patients with acute coronary syndrome
by: I. B. Ryzhikova, et al.
Published: (1970-01-01)

Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older
by: L. A. Ratnikova, et al.
Published: (2012-08-01)

Клиническая фармакология ацетилсалициловой кислоты и особенности лекарственных форм – ключ к эффективному и безопасному применению для профилактики тромбозов
Published: (2016-12-01)

«НЕПОТЕРЯННОЕ ВРЕМЯ» В ПРОФИЛАКТИКЕ РАЗВИТИЯ ОСЛОЖНЕНИЙ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ: ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ПРИМЕНЕНИЯ СТАТИНОВ С ЦЕЛЬЮ ПЕРВИЧНОЙ ПРОФИЛАКТИКИ
Published: (2016-12-01)

Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01)

Issledovanie ONTARGET: Telmisartan ne ustupaet po effektivnosti ramiprilu u patsientov s vysokim riskom serdechno-sosudistykh oslozhneniy / sakharnym diabetom
by: Olga Konstantinovna Vikulova, et al.
Published: (2008-06-01)

General characteristics and gender specifics of cardiovascular patients in ambulatory practice
by: I. V. Samorodskaya, et al.
Published: (1970-01-01)

Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition
by: I. Dedov, et al.
Published: (2024-01-01)

Pathogenetics aspects of relationship mouth infectious diseases with development and progression atherosclerosis and possibility for their integrated prevention
by: M. V. Avdeeva, et al.
Published: (2014-09-01)

ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK
by: M. N. Kovrigina, et al.
Published: (2015-12-01)

Ацетилсалициловая кислота в первичной профилактике сердечно-сосудистых заболеваний: уточненные данные
Published: (2018-06-01)

Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01)

Evaluation of cardiovascular risk factors for medical workers of an urban multidisciplinary hospital
by: K. G. Tkachenko, et al.
Published: (2019-09-01)

Preliminary results of the implementation of the program to reduce morbidity and prevent mortality from diseases of the circulatory system in workers of locomotive crews
by: E. A. Zhidkova, et al.
Published: (2022-10-01)

Modern Aspects of the Clinic, Diagnosis and Treatment of Prediabetes
by: N. V. Pyrikova, et al.
Published: (2020-10-01)

Novaya vekha v ispol'zovani statinov dlya profilaktiki i lecheniya serdechno-sosudistykh oslozhneniy (Po rezul'tatam Heart Protection Study ? HPS)
by: L Chugunova, et al.
Published: (2003-12-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Urgent prevention in cardiovascular disease
by: V. V. Ruksin
Published: (2005-04-01)

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW
by: S. R. Gilyarevskiy, et al.
Published: (2016-01-01)

Acetylsalicylic acid in the primary prevention of vascular complications in patients without clinically apparent atherosclerosis: how to balance risk and benefit?
by: A. L. Komarov
Published: (2023-01-01)

Issledovanie ADVANCE: vliyanie Noliprela - fiksirovannoy kombinatsii ingibitora APF (Perindoprila) i diuretika (Indapamida) - na razvitie serdechno-sosudistykh oslozhneniy u patsientov s sakharnym diabetom 2 tipa
by: Marina Vladimirovna Shestakova, et al.
Published: (2008-03-01)

CARDIOPSYCHIATRY. A CLASH OF OPINIONS
by: M. Yu. Drobizhev
Published: (2017-04-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)

Modern views on erectile dysfunction and new methods for its treatment
by: A. L. Vertkin, et al.
Published: (2005-06-01)

Lifelong prevention of cardiovascular disease. Part I: preconceptional, prenatal and infant periods of life
by: O. V. Kopylova, et al.
Published: (2020-12-01)